ePaper
Home
Live Blog
Breaking News
Top Headlines
Cities
NE News
Sentinel Media
Sports
Education
Jobs
Home
Live Blog
Breaking News
Top Headlines
Cities
NE News
Sentinel Media
Sports
Education
Jobs
Drug Controller General of India
Biological E gets DCGI nod to conduct phase 2/3 trials on children
02 Sep 2021
A decisive turning point to strengthen a spirited fight: PM Narendra Modi
03 Jan 2021
Sputnik-V COVID-19 vaccine gets nod for clinical trials in India
17 Oct 2020
Tata CRISPR received regulatory approval for COVID test
19 Sep 2020
Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet
06 Aug 2020
Cipla gets DCGI nod to sell Favipiravir under brand 'Ciplenza'
25 Jul 2020
DCGI sends notice to Glenmark for false claims, overpricing of COVID-19 drug FabiFlu
19 Jul 2020
Biophore India Pharmaceuticals ramps up Favipiravir production
15 Jul 2020
Sentinel Assam
www.sentinelassam.com
INSTALL APP